---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-156049"
form_type: "8-K"
ticker: "STOK"
cik: "0001623526"
company_name: "Stoke Therapeutics, Inc."
filed_at: "2024-06-06T23:59:59+00:00"
generated_at: "2026-06-01T05:54:45.036625+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Stoke Therapeutics shareholders elect three Class II directors, ratify KPMG as auditor

## Summary
- Elected Jennifer C. Burstein, Arthur A. Levin, Ph.D., and Ian F. Smith as Class II directors for three-year terms.
- Burstein received 32,396,633 votes for; Levin 25,556,568 for; Smith 33,961,032 for; broker non-votes 5,561,508 each.
- Ratified KPMG as independent auditor for fiscal 2024 with 39,911,634 votes for, 6,826 against, 9,898 abstentions.

## SEC filing metadata
- accession: 0001193125-24-156049
- form_type: 8-K
- ticker: STOK
- cik: 0001623526
- company_name: Stoke Therapeutics, Inc.
- filed_at: 2024-06-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1623526/000119312524156049/0001193125-24-156049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1623526/000119312524156049/d795894d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-156049
- JSON: https://secwatch.observer/filing/0001193125-24-156049.json
- Plain text: https://secwatch.observer/filing/0001193125-24-156049.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.